{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T01:00:59Z","timestamp":1794877259317,"version":"4.9.1"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":327,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"The IPF-PRO Registry is supported by Boehringer Ingelheim Pharmaceuticals, Inc and run in collaboration with the Duke Clinical Research Institute (DCRI) and enrolling centers"},{"name":"The IPF-PRO Registry is supported by Boehringer Ingelheim Pharmaceuticals, Inc and run in collaboration with the Duke Clinical Research Institute (DCRI) and enrolling centers"}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Although exposure to air pollution is a known risk factor for adverse pulmonary outcomes, its impact in individuals with idiopathic pulmonary fibrosis (IPF) is less well understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To investigate the effects of long-term exposure to air pollution on disease severity and progression in patients with IPF and to determine whether genomic factors, such as MUC5B promoter polymorphism or telomere length, modify these associations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed analyses at enrollment and after 1 year of follow-up in the IPF-PRO (Idiopathic Pulmonary Fibrosis Prospective Outcomes) Registry, a prospective observational registry that enrolled individuals with IPF at 46 U.S. sites from June 2014 to October 2018. Five-year average pollution exposures (particulate matter \u22642.5 \u03bcm in aerodynamic diameter [PM2.5], nitrogen dioxide, ozone) before the enrollment date were estimated at participants\u2019 residential addresses with validated national spatiotemporal models. Multivariable regression models estimated associations between pollution exposure and physiologic measurements (forced vital capacity [FVC], diffusing capacity of the lung for carbon monoxide, supplemental oxygen use at rest) and quality-of-life measurements (St. George\u2019s Respiratory Questionnaire, EuroQoL, Cough and Sputum Assessment Questionnaire) at enrollment. Cox proportional hazards models estimated associations between pollutants and a composite outcome of death, lung transplant, or &amp;gt;10% absolute decline in FVC percent predicted in the year after enrollment. Models were adjusted for individual-level and spatial confounders, including proxies for disease onset. Gene\u2013environment interactions with MUC5B and telomere length were assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 835 participants, 94% were non-Hispanic White individuals, 76% were male, and the mean (standard deviation) age was 70 (7.7) years. In fully adjusted analyses, higher PM2.5 exposure was associated with worse quality of life per St. George\u2019s Respiratory Questionnaire activity score (3.48 [95% confidence interval (CI), 0.64, 6.32] per 2 \u03bcg\/m3 PM2.5) and EuroQoL scores (\u22120.04 [95% CI, \u22120.06, \u22120.01] per 2 \u03bcg\/m3 PM2.5), as well as lower FVC percent predicted and lower diffusing capacity of the lung for carbon monoxide percent predicted at enrollment. Each 3 parts per billion difference in O3 exposure was associated with a 1.57% (95% CI, 0.15, 2.98) higher FVC percent predicted at enrollment, although this effect was attenuated in multipollutant models. There was no association between nitrogen dioxide and enrollment measures or between pollution exposure and 1-year outcomes and no evidence for gene\u2013environment interactions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In the IPF-PRO Registry, long-term exposure to PM2.5 was associated with worse quality of life and lung function at enrollment, but not with short-term disease progression or mortality. There was no evidence of effect modification by interaction of genomic factors with pollution. The reason for the unexpected relationship between O3 exposure and higher FVC is unclear.<\/jats:p>\n                    <jats:p>Clinical trial registered with www.clinicaltrials.gov (NCT01915511).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1513\/annalsats.202404-382oc","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T16:12:12Z","timestamp":1731427932000},"page":"378-386","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":11,"title":["Long-Term Air Pollution Exposure and Severity of Idiopathic Pulmonary Fibrosis: Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry"],"prefix":"10.1093","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1825-6066","authenticated-orcid":false,"given":"Coralynn","family":"Sack","sequence":"first","affiliation":[{"name":"University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3431-2014","authenticated-orcid":false,"given":"Daniel M.","family":"Wojdyla","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0232-3263","authenticated-orcid":false,"given":"Maeve G.","family":"MacMurdo","sequence":"additional","affiliation":[{"name":"Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0889-7460","authenticated-orcid":false,"given":"Amanda","family":"Gassett","sequence":"additional","affiliation":[{"name":"University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4174-9037","authenticated-orcid":false,"given":"Joel D.","family":"Kaufman","sequence":"additional","affiliation":[{"name":"University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7506-6643","authenticated-orcid":false,"given":"Ganesh","family":"Raghu","sequence":"additional","affiliation":[{"name":"University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6486-6725","authenticated-orcid":false,"given":"Carrie A.","family":"Redlich","sequence":"additional","affiliation":[{"name":"Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5110-6150","authenticated-orcid":false,"given":"Peide","family":"Li","sequence":"additional","affiliation":[{"name":"Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5368-0412","authenticated-orcid":false,"given":"Amy L.","family":"Olson","sequence":"additional","affiliation":[{"name":"Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3098-4330","authenticated-orcid":false,"given":"Thomas B.","family":"Leonard","sequence":"additional","affiliation":[{"name":"Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4247-3693","authenticated-orcid":false,"given":"Jamie L.","family":"Todd","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Durham, North Carolina"},{"name":"Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0101-1081","authenticated-orcid":false,"given":"Megan L.","family":"Neely","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Durham, North Carolina"},{"name":"Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5962-2184","authenticated-orcid":false,"given":"Laurie D.","family":"Snyder","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Durham, North Carolina"},{"name":"Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4082-1351","authenticated-orcid":false,"given":"Mridu","family":"Gulati","sequence":"additional","affiliation":[{"name":"Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,3,1]]},"reference":[{"key":"2026012203114906700_bib1","doi-asserted-by":"crossref","first-page":"200093","DOI":"10.1183\/16000617.0093-2020","article-title":"Fibrotic interstitial lung diseases and air pollution: a systematic literature review","volume":"29","author":"Harari","year":"2020","journal-title":"Eur Respir Rev"},{"key":"2026012203114906700_bib2","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1183\/09031936.00122213","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis associated with air pollution exposure","volume":"43","author":"Johannson","year":"2014","journal-title":"Eur Respir J"},{"key":"2026012203114906700_bib3","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.chest.2017.07.034","article-title":"Exposure to ambient particulate matter is associated with accelerated functional decline in idiopathic pulmonary fibrosis","volume":"153","author":"Winterbottom","year":"2018","journal-title":"Chest"},{"key":"2026012203114906700_bib4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/thoraxjnl-2017-209967","article-title":"Role of atmospheric pollution on the natural history of idiopathic pulmonary fibrosis","volume":"73","author":"Ses\u00e9","year":"2018","journal-title":"Thorax"},{"key":"2026012203114906700_bib5","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.chest.2020.02.017","article-title":"The association between air pollution and hospitalization of patients with idiopathic pulmonary fibrosis in Chile: a daily time series analysis","volume":"158","author":"Dales","year":"2020","journal-title":"Chest"},{"key":"2026012203114906700_bib6","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1001\/jamainternmed.2022.4696","article-title":"Association of particulate matter exposure with lung function and mortality among patients with fibrotic interstitial lung disease","volume":"182","author":"Goobie","year":"2022","journal-title":"JAMA Intern Med"},{"key":"2026012203114906700_bib7","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/resp.14552","article-title":"Long-term exposure to low concentrations of air pollution and decline in lung function in people with idiopathic pulmonary fibrosis: evidence from Australia","volume":"28","author":"Zheng","year":"2023","journal-title":"Respirology"},{"key":"2026012203114906700_bib8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.chest.2018.01.015","article-title":"Air pollution exposure is associated with lower lung function, but not changes in lung function, in patients with idiopathic pulmonary fibrosis","volume":"154","author":"Johannson","year":"2018","journal-title":"Chest"},{"key":"2026012203114906700_bib9","doi-asserted-by":"crossref","first-page":"2001877","DOI":"10.1183\/13993003.01877-2020","article-title":"Nitrogen dioxide increases the risk of mortality in idiopathic pulmonary fibrosis","volume":"57","author":"Yoon","year":"2021","journal-title":"Eur Respir J"},{"key":"2026012203114906700_bib10","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1513\/AnnalsATS.202305-495RL","article-title":"Impact of air pollution and MUC5B genotype on survival in idiopathic pulmonary fibrosis","volume":"21","author":"Ses\u00e9","year":"2024","journal-title":"Ann Am Thorac Soc"},{"key":"2026012203114906700_bib11","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1164\/rccm.202307-1275OC","article-title":"Ambient ultrafine particulate matter and clinical outcomes in fibrotic interstitial lung disease","volume":"209","author":"Goobie","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203114906700_bib12","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/resp.14373","article-title":"Nitrogen dioxide increases the risk of disease progression in idiopathic pulmonary fibrosis","volume":"28","author":"Yoon","year":"2023","journal-title":"Respirology"},{"key":"2026012203114906700_bib13","doi-asserted-by":"crossref","first-page":"87004","DOI":"10.1289\/EHP4041","article-title":"Exposure\u2013response associations of household air pollution and buccal cell telomere length in women using biomass stoves","volume":"127","author":"Li","year":"2019","journal-title":"Environ Health Perspect"},{"key":"2026012203114906700_bib14","doi-asserted-by":"crossref","first-page":"e10680","DOI":"10.1371\/journal.pone.0010680","article-title":"Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations","volume":"5","author":"Diaz de Leon","year":"2010","journal-title":"PLoS One"},{"key":"2026012203114906700_bib15","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1001\/jama.2013.5827","article-title":"Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis","volume":"309","author":"Peljto","year":"2013","journal-title":"JAMA"},{"key":"2026012203114906700_bib16","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1038\/s41467-018-07768-9","article-title":"Muc5b overexpression causes mucociliary dysfunction and enhances lung fibrosis in mice","volume":"9","author":"Hancock","year":"2018","journal-title":"Nat Commun"},{"key":"2026012203114906700_bib17","doi-asserted-by":"crossref","first-page":"e000108","DOI":"10.1136\/bmjresp-2015-000108","article-title":"Rationale for and design of the Idiopathic Pulmonary Fibrosis\u2013Prospective Outcomes (IPF-PRO) Registry","volume":"3","author":"O\u2019Brien","year":"2016","journal-title":"BMJ Open Respir Res"},{"key":"2026012203114906700_bib18","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203114906700_bib19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1289\/ehp.1408145","article-title":"A unified spatiotemporal modelling approach for predicting concentrations of multiple air pollutants in the multi-ethnic study of atherosclerosis and air pollution","volume":"123","author":"Keller","year":"2015","journal-title":"Environ Health Perspect"},{"key":"2026012203114906700_bib20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.atmosenv.2015.10.042","article-title":"Development of long-term spatiotemporal models for ambient ozone in six metropolitan regions of the United States: the MESA Air study","volume":"123","author":"Wang","year":"2015","journal-title":"Atmos Environ (1994)"},{"key":"2026012203114906700_bib21","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1021\/acs.est.5b05099","article-title":"Satellite-based NO2 and model validation in a national prediction model based on universal kriging and land-use regression","volume":"50","author":"Young","year":"2016","journal-title":"Environ Sci Technol"},{"key":"2026012203114906700_bib22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s40572-021-00310-y","article-title":"Fine-scale air pollution models for epidemiologic research: insights from approaches developed in the Multi-Ethnic Study of Atherosclerosis and Air Pollution (MESA Air)","volume":"8","author":"Kirwa","year":"2021","journal-title":"Curr Environ Health Rep"},{"key":"2026012203114906700_bib23","article-title":"A national spatiotemporal model for ambient ozone concentration in the United States using universal kriging and land-use regression: 2005-2014","author":"Young","year":"2020","journal-title":"Environ Health Persp"},{"key":"2026012203114906700_bib24","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1183\/09031936.00080312","article-title":"Multi-ethnic reference values for spirometry for the 3-95-yr age range: the Global Lung Function 2012 equations","volume":"40","author":"Quanjer","year":"2012","journal-title":"Eur Respir J"},{"key":"2026012203114906700_bib25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0954-6111(06)80166-6","article-title":"The St George\u2019s Respiratory Questionnaire","volume":"85 Suppl B","author":"Jones","year":"1991","journal-title":"Respir Med"},{"key":"2026012203114906700_bib26","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.rmed.2008.06.009","article-title":"Development and validation of a cough and sputum assessment questionnaire","volume":"102","author":"Crawford","year":"2008","journal-title":"Respir Med"},{"key":"2026012203114906700_bib27","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/07853890109002087","article-title":"EQ-5D: a measure of health status from the EuroQol Group","volume":"33","author":"Rabin","year":"2001","journal-title":"Ann Med"},{"key":"2026012203114906700_bib28","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","article-title":"A 12-item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity","volume":"34","author":"Ware","year":"1996","journal-title":"Med Care"},{"key":"2026012203114906700_bib29","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/jamacardio.2020.6500","article-title":"Assessing the role of rare genetic variation in patients with heart failure","volume":"6","author":"Povysil","year":"2021","journal-title":"JAMA Cardiol"},{"key":"2026012203114906700_bib30","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1093\/nar\/gku181","article-title":"Estimating telomere length from whole genome sequence data","volume":"42","author":"Ding","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"2026012203114906700_bib31","doi-asserted-by":"crossref","first-page":"100084","DOI":"10.1016\/j.xgen.2021.100084","article-title":"Genetic determinants of telomere length from 109,122 ancestrally diverse whole-genome sequences in TOPMed","volume":"2","author":"Taub","year":"2022","journal-title":"Cell Genom"},{"key":"2026012203114906700_bib32","article-title":"Geographic levels","author":"U.S. Census Bureau"},{"key":"2026012203114906700_bib33","article-title":"CDC\/ATSDR SVI data and documentation download: place and health","author":"Agency for Toxic Substances and Disease Registry (ATSDR)"},{"key":"2026012203114906700_bib34","first-page":"3","article-title":"A social vulnerability index for disaster management","volume":"8","author":"Flanagan","year":"2011","journal-title":"J Homel Secur Emerg Manag"},{"key":"2026012203114906700_bib35","doi-asserted-by":"crossref","first-page":"1801563","DOI":"10.1183\/13993003.01563-2018","article-title":"Hypersensitivity pneumonitis and its correlation with ambient air pollution in urban India","volume":"53","author":"Singh","year":"2019","journal-title":"Eur Respir J"},{"key":"2026012203114906700_bib36","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3390\/ijerph15061077","article-title":"Short-term particulate air pollution exposure is associated with increased severity of respiratory and quality of life symptoms in patients with fibrotic sarcoidosis","volume":"15","author":"Pirozzi","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"2026012203114906700_bib37","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12955-014-0124-1","article-title":"The psychometric properties of the St George\u2019s Respiratory Questionnaire (SGRQ) in patients with idiopathic pulmonary fibrosis: a literature review","volume":"12","author":"Swigris","year":"2014","journal-title":"Health Qual Life Outcomes"},{"key":"2026012203114906700_bib38","doi-asserted-by":"crossref","first-page":"210026","DOI":"10.1183\/16000617.0026-2021","article-title":"Patient-reported outcomes and patient-reported outcome measures in interstitial lung disease: where to go from here?","volume":"30","author":"Kalluri","year":"2021","journal-title":"Eur Respir Rev"},{"key":"2026012203114906700_bib39","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1749-6632.2010.05604.x","article-title":"Acute effects of motor vehicle traffic-related air pollution exposures on measures of oxidative stress in human airways","volume":"1203","author":"Laumbach","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"2026012203114906700_bib40","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1001\/jama.2019.10255","article-title":"Association between long-term exposure to ambient air pollution and change in quantitatively assessed emphysema and lung function","volume":"322","author":"Wang","year":"2019","journal-title":"JAMA"},{"key":"2026012203114906700_bib41","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1001\/jamainternmed.2019.5498","article-title":"Association of long-term ambient ozone exposure with respiratory morbidity in smokers","volume":"180","author":"Paulin","year":"2020","journal-title":"JAMA Intern Med"},{"key":"2026012203114906700_bib42","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1513\/AnnalsATS.201606-458OC","article-title":"Acute exacerbation and decline in forced vital capacity are associated with increased mortality in idiopathic pulmonary fibrosis","volume":"14","author":"Paterniti","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"2026012203114906700_bib43","doi-asserted-by":"crossref","first-page":"2200777","DOI":"10.1183\/13993003.00777-2022","article-title":"Air pollutants, genetic susceptibility and risk of incident idiopathic pulmonary fibrosis","volume":"61","author":"Cui","year":"2023","journal-title":"Eur Respir J"},{"key":"2026012203114906700_bib44","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1164\/rccm.201506-1063ST","article-title":"An official ATS\/ERS\/JRS\/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline","volume":"192","author":"Raghu","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203114906700_bib45","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"198","author":"Raghu","year":"2018","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/22\/3\/378\/66008116\/annalsats_22_3_378.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/22\/3\/378\/66008116\/annalsats_22_3_378.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T08:12:20Z","timestamp":1769069540000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/22\/3\/378\/8380624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,1]]},"references-count":45,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3,1]]},"published-print":{"date-parts":[[2025,3,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.202404-382oc","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,3]]},"published":{"date-parts":[[2025,3,1]]},"assertion":[{"value":"2024-04-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}